Post Immunization Adverse Events (AEFI) of COVID-19 Vaccine in One of Indonesian Private University’s Students
DOI:
https://doi.org/10.36916/jkm.v9i1.235Keywords:
covid-19, KIPI, VaksinAbstract
Background: Vaccination is an option used to prevent the spread of COVID-19. Vaccination is a very reliable primary prevention measure against disease. As for the implementation of vaccination activities, it will cause a reaction known as a Post-Immunization Adverse Event (AEFI).
Methods: Quantitative method with descriptive analytic design. Sampling
using a total sampling technique with a total of 235 student respondents.
The research instrument was the AEFI incidence questionnaire. This study
was conducted from February 01 to 28, 2022 with univariate data analysis.
Result: The type of vaccine that caused the most AEFI was the Sinovac
vaccine. The type of AEFI experienced by most respondents was pain in the
injection area, totaling 100 respondents (92.6%), and the types of AEFI that were not experienced by respondents were fainting and axillary gland enlargement.
Implications: The COVID-19 vaccine raises KIPI, the most common of
which is pain in the injection area. Pain is one of the local reactions of KIPI
that falls into the mild category and can be immediately resolved with a cold
compress on the painful area.
Keywords: COVID-19; AEFI; Vaccines
References
Aulia, D. (2022). Evaluasi Kejadian Ikutan Pasca Imunisasi Vaksin Covid19 Pada
Masyarakat Di Kelurahan Panarung Kota Palangka Raya [17 Agustus 1945 Jakarta].
http://repository.uta45jakarta.ac.id/149/1/Devi Aulia_Full Text.pdf
Balai Penelitian dan Pengembangan Kesehatan Baturaja. (2021). Kejadian Ikutan Paska
Imunisasi (KIPI) Pada Vaksinasi COVID-19. Badan Penelitian Dan Pengembangan
Kesehatan Kementerian RI. https://www.balaibaturaja.litbang.kemkes.go.id/readkejadian-ikutan-paska-imunisasi-kipi-pada-vaksinasi-covid19
Basuki, A. R., Mayasari, G., & Handayani, E. (2022). Gambaran KIPI ( Kejadian Ikutan
Pasca Imunisasi ) Pada Karyawan Rumah Sakit Yang Mendapatkan Imunisasi Dengan
Vaksin Sinovac Di RSUD Kota Yogyakarta. Majalah Farmaseutik, 18(1), 30–36.
https://doi.org/10.22146/farmaseutik.v18i1.71908
Budiyanti, R. T., & Ganggi, R. I. P. (2021). Serba-serbi Vaksinasi COVID-19. CV. Asta Karya
Kreatifa Media.
Dewi, S. A. E. (2021). Komunikasi Publik Terkait Vaksinasi Covid 19. Health Care : Jurnal
Kesehatan, 10(1), 162–167. https://doi.org/10.36763/healthcare.v10i1.119
Green, M. S., Peer, V., Magid, A., Hagani, N., Anis, E., & Nitzan, D. (2022). Gender
Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine.
Vaccines, 10(2). https://doi.org/10.3390/vaccines10020233
Kementerian Kesehatan Republik Indonesia. (2021). Pelaksanaan Vaksinasi COVID-19.
https://dashboardcovid19.kemkes.go.id/
Aulia, D. (2022). Evaluasi Kejadian Ikutan Pasca Imunisasi Vaksin Covid19 Pada
Masyarakat Di Kelurahan Panarung Kota Palangka Raya [17 Agustus 1945 Jakarta].
http://repository.uta45jakarta.ac.id/149/1/Devi Aulia_Full Text.pdf
Balai Penelitian dan Pengembangan Kesehatan Baturaja. (2021). Kejadian Ikutan Paska
Imunisasi (KIPI) Pada Vaksinasi COVID-19. Badan Penelitian Dan Pengembangan
Kesehatan Kementerian RI. https://www.balaibaturaja.litbang.kemkes.go.id/readkejadian-ikutan-paska-imunisasi-kipi-pada-vaksinasi-covid19
Basuki, A. R., Mayasari, G., & Handayani, E. (2022). Gambaran KIPI ( Kejadian Ikutan
Pasca Imunisasi ) Pada Karyawan Rumah Sakit Yang Mendapatkan Imunisasi Dengan
Vaksin Sinovac Di RSUD Kota Yogyakarta. Majalah Farmaseutik, 18(1), 30–36.
https://doi.org/10.22146/farmaseutik.v18i1.71908
Budiyanti, R. T., & Ganggi, R. I. P. (2021). Serba-serbi Vaksinasi COVID-19. CV. Asta Karya
Kreatifa Media.
Dewi, S. A. E. (2021). Komunikasi Publik Terkait Vaksinasi Covid 19. Health Care : Jurnal
Kesehatan, 10(1), 162–167. https://doi.org/10.36763/healthcare.v10i1.119
Green, M. S., Peer, V., Magid, A., Hagani, N., Anis, E., & Nitzan, D. (2022). Gender
Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine.
Vaccines, 10(2). https://doi.org/10.3390/vaccines10020233
Kementerian Kesehatan Republik Indonesia. (2021). Pelaksanaan Vaksinasi COVID-19.
https://dashboardcovid19.kemkes.go.id/
Republik Indonesia Kabinet, S. (2021). Vaksinasi Segera Dimulai, Presiden: 329,5 Juta
Dosis Vaksin COVID-19 Telah Dipesan. https://setkab.go.id/vaksinasi-segera-dimulaipresiden-3295-juta-dosis-vaksin-COVID-19-telah-dipesan/
Saeed, B.Q., Al-Shahrabi, R., Alhaj, S.S., Alkokhardi, Z.M. and Adrees, A. O. (2021). Side
effects and perceptions following Sinopharm COVID-19 vaccination. International
Journal of Infectious Diseases.
UNICEF. (2021). Vaksin COVID-19 dan KIPI.
https://www.unicef.org/indonesia/id/media/9896/file/Booklet_Vaksin_COVID-
_%26_KIPI.pdf
Usach, I., Martinez, R., Festini, T., & Peris, J.-E. (2019). Subcutaneous Injection of Drugs:
Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances
in Therapy, 36, 2986–2996. https://doi.org/10.6084/m9.figshare.9861800
World Health Organization (WHO). (2018). Vaccine Safety Basics.
https://openwho.org/courses/vaccine-safety-basics
World Health Organization (WHO). (2021). Coronavirus (COVID-19) Dashboard.
https://data.who.int/dashboards/covid19/cases?n=c
Zeng, F., Dai, C., Cai, P., Wang, J., Xu, L., Li, J., Hu, G., Wang, Z., Zheng, F., & Wang, L.
(2020). A comparison study of SARS-CoV-2 IgG antibody between male and female
COVID-19 patients: A possible reason underlying different outcome between sex.
Journal of Medical Virology, 92(10), 2050–2054. https://doi.org/10.1002/jmv.25989
Zhu, J. S., Zhang, M. X., Chien, C. W., Yang, W. Y., Shi, G. F., Qiu, S., Tung, T. H., & Chen,
H. X. (2021). Sex Differences in Adverse Reactions to an Inactivated SARS-CoV-2
Vaccine Among Medical Staff in China. Frontiers in Medicine, 8.
Downloads
Published
Issue
Section
Citation Check
License
Copyright (c) 2024 Ballsy Cicilia Albertina Pangkey, Dian Riccen Manullang, Maya Rani Simbolon, Ranita Fitriani Naibaho, Masruda A Panjaitan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
